<DOC>
	<DOCNO>NCT02156063</DOCNO>
	<brief_summary>This randomise , double blind , multi-center , placebo-controlled study subcutaneous NT100 pregnant woman history unexplained recurrent pregnancy loss . Approximately 150 participant randomise receive subcutaneous NT100 placebo .</brief_summary>
	<brief_title>A Multi-center , Placebo-controlled Study Evaluate NT100 Pregnant Women With History Unexplained Recurrent Pregnancy Loss ( RPL )</brief_title>
	<detailed_description>This randomise , double blind , multi-center , placebo-controlled study subcutaneous NT100 pregnant woman history unexplained recurrent pregnancy loss . Approximately 150 participant randomise receive subcutaneous NT100 placebo . Participants screen eligibility , begin attempt spontaneous conception . Following randomization initiation study drug treatment , participant visit study site specify interval throughout study assessment blood work . All participant monitor adverse event . All participant receive least one dose study drug follow safety minimum 4 week follow last dose study drug . After delivery , pregnancy outcome information obtain .</detailed_description>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<criteria>1 . Premenopausal female 1837 year age consent , try conceive 2 . Documented history unexplained recurrent pregnancy loss 3 . Spontaneous conception , confirm urine pregnancy test perform investigative site 4 . Body mass index ( BMI ) 1935 kg/m2 consent 1 . Greater 5 week gestation present randomisation . 2 . Known karyotype abnormality either participant current male partner 3 . Uncorrected clinically significant intrauterine abnormality 4 . Abnormal vaginal bleed unknown cause 5 . Current diagnosis infertility either participant current male partner 6 . Current past diagnosis systemic autoimmune disease , coagulopathy , hyperprolactinemia , cervical incompetence , highgrade cervical dysplasia conization/surgery . 7 . Any uncontrolled clinically significant medical condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Recurrent Pregnancy Loss</keyword>
	<keyword>Recurrent Miscarriage</keyword>
	<keyword>Miscarriage</keyword>
	<keyword>Pregnancy Loss</keyword>
	<keyword>Repeated Pregnancy Loss</keyword>
</DOC>